"ada standards of care (2025): pharmacologic approaches" MCQ (SBA): Type 2 Diabetes Mellitus with ASCVD

Instant feedback + full explanation. One question, done properly.

Moderatedulaglutide) or an SGLT2 inhibitor for patients with ASCVDType 2 Diabetes Mellitus with ASCVD"ada standards of care (2025): pharmacologic approaches"

A 50-year-old with type 2 diabetes and ASCVD is on metformin. A1c is 7.8%. Which medication class should be added for cardiovascular benefit per ADA?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.